An innovative method to study target protein-drug interactions by mass spectrometry

J Med Chem. 2009 May 14;52(9):2875-9. doi: 10.1021/jm9000665.

Abstract

We report the combination of chemical cross-linking and high-resolution mass spectrometry for analyzing conformational changes in target proteins that are induced by drug binding. With this approach conformational changes in the peroxisome proliferator-activated receptor alpha (PPARalpha) upon binding of low-molecular weight compounds were readily detected, proving that the strategy provides a basis to efficiently characterize target protein-drug interactions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Crystallography, X-Ray
  • Drug Discovery
  • Hydrolysis
  • Ligands
  • Mass Spectrometry
  • Models, Molecular
  • Oxazoles / chemistry
  • Oxazoles / metabolism
  • Oxazoles / pharmacology
  • PPAR alpha / agonists
  • PPAR alpha / antagonists & inhibitors
  • PPAR alpha / chemistry
  • PPAR alpha / metabolism*
  • Pharmaceutical Preparations / chemistry
  • Pharmaceutical Preparations / metabolism*
  • Protein Binding
  • Protein Conformation / drug effects
  • Reproducibility of Results
  • Tyrosine / analogs & derivatives
  • Tyrosine / chemistry
  • Tyrosine / metabolism
  • Tyrosine / pharmacology

Substances

  • GW 6471
  • Ligands
  • Oxazoles
  • PPAR alpha
  • Pharmaceutical Preparations
  • Tyrosine